Antiretroviral Therapy for Acute HIV Infection.

Trial Profile

Antiretroviral Therapy for Acute HIV Infection.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Maraviroc; Raltegravir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms AAHIV
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Jan 2017 Planned number of patients changed from 150 to 500.
    • 17 Jun 2016 Results from NCT00796146 and NCT00796263 trials (n=234) published in the Clinical Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top